ID30484A - Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin - Google Patents

Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin

Info

Publication number
ID30484A
ID30484A IDW00200101897A ID20011897A ID30484A ID 30484 A ID30484 A ID 30484A ID W00200101897 A IDW00200101897 A ID W00200101897A ID 20011897 A ID20011897 A ID 20011897A ID 30484 A ID30484 A ID 30484A
Authority
ID
Indonesia
Prior art keywords
methods
phenoxic
heterosiclicsulfonamidyl
endoteline
derunan
Prior art date
Application number
IDW00200101897A
Other languages
English (en)
Indonesian (id)
Inventor
Volker Breu
Phillippe Coassolo
Werner Neidhart
Sebastien Roux
Peter Weiss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID30484A publication Critical patent/ID30484A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IDW00200101897A 1999-03-03 2000-02-28 Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin ID30484A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99104306 1999-03-03

Publications (1)

Publication Number Publication Date
ID30484A true ID30484A (id) 2001-12-13

Family

ID=8237697

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101897A ID30484A (id) 1999-03-03 2000-02-28 Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin

Country Status (30)

Country Link
US (2) US6417360B1 (de)
EP (1) EP1185525B1 (de)
JP (1) JP3488203B2 (de)
KR (1) KR100478798B1 (de)
CN (1) CN1342158B (de)
AR (1) AR044720A1 (de)
AT (1) ATE353325T1 (de)
AU (1) AU756738B2 (de)
BR (1) BR0008717A (de)
CA (1) CA2364906C (de)
CY (1) CY1108002T1 (de)
CZ (1) CZ300324B6 (de)
DE (1) DE60033280T2 (de)
DK (1) DK1185525T3 (de)
ES (1) ES2280198T3 (de)
HK (1) HK1044943B (de)
HR (1) HRP20010630B1 (de)
HU (1) HUP0200080A3 (de)
ID (1) ID30484A (de)
IL (1) IL145051A0 (de)
MA (1) MA26776A1 (de)
NO (1) NO320809B1 (de)
NZ (1) NZ513671A (de)
PL (1) PL198815B1 (de)
PT (1) PT1185525E (de)
RS (1) RS50109B (de)
RU (1) RU2201928C1 (de)
TR (1) TR200102562T2 (de)
WO (1) WO2000052007A1 (de)
ZA (1) ZA200107157B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140724A (en) 2000-07-21 2010-01-15 Actelion Pharmaceuticals Ltd Novel arylethene-sulfonamides
US20020184047A1 (en) * 2001-04-03 2002-12-05 Plotnick Michael A. Universal ad queue
EP1454625A1 (de) * 2003-03-06 2004-09-08 Speedel Development AG Pyridylsulfonamidyl-pyrimidine zur Behandlung von diabetischen nephropathien
EP1595880A1 (de) * 2004-05-13 2005-11-16 Speedel Pharma AG Kristallforme eines Pyridinylsulfonamids und deren Verwendung als Endothelinrezeptorantagonisten
WO2007031501A2 (en) * 2005-09-12 2007-03-22 Speedel Pharma Ag Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure
SG174050A1 (en) * 2006-04-13 2011-09-29 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
EP1938812A1 (de) * 2006-12-22 2008-07-02 Speedel Pharma AG Pharmazeutische Zubereitung unter Verwendung von Aliskiren und Avosentan
US20100093758A1 (en) * 2008-07-23 2010-04-15 Auspex Pharmaceuticals, Inc. Pyridine sulfonamide modulators of endothelin-a receptor
EP3250557B1 (de) 2015-01-29 2024-11-20 Signal Pharmaceuticals, LLC Isotopologe von 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidin-5-carboxamid
KR101936054B1 (ko) 2017-06-23 2019-01-11 한국과학기술연구원 항염증 활성을 가지는 6-페녹시피리미딘 유도체, 이의 제조방법 및 이를 활성성분으로 하는 약학 조성물
JP7820522B2 (ja) 2021-12-17 2026-02-25 ネクセラファーマ株式会社 クラゾセンタン二ナトリウム塩、その製造及びそれを含有する医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400354D0 (en) * 1984-01-07 1984-02-08 Pfizer Ltd Therapeutic agents
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
CA2162630C (en) 1994-11-25 2007-05-01 Volker Breu Sulfonamides
CN1064965C (zh) * 1994-11-25 2001-04-25 弗·哈夫曼-拉罗切有限公司 新的磺酰胺类化合物及其作为药物的用途
US5837708A (en) 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
TW313568B (de) 1994-12-20 1997-08-21 Hoffmann La Roche
DK0897914T3 (da) 1997-08-19 2004-09-27 Hoffmann La Roche Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner
TWI284642B (en) * 1999-01-18 2007-08-01 Hoffmann La Roche Novel heterocyclic sulfonamides

Also Published As

Publication number Publication date
RU2001126348A (ru) 2004-03-20
ATE353325T1 (de) 2007-02-15
CZ300324B6 (cs) 2009-04-22
DE60033280D1 (de) 2007-03-22
CY1108002T1 (el) 2013-09-04
HK1044943B (zh) 2013-03-22
AU3161100A (en) 2000-09-21
IL145051A0 (en) 2002-06-30
HRP20010630B1 (hr) 2010-08-31
PL351794A1 (en) 2003-06-16
NO20014224D0 (no) 2001-08-31
HUP0200080A3 (en) 2003-01-28
RS50109B (sr) 2009-03-25
NO320809B1 (no) 2006-01-30
ZA200107157B (en) 2002-11-29
YU62801A (sh) 2004-07-15
CZ20013108A3 (cs) 2002-02-13
BR0008717A (pt) 2001-12-26
HK1044943A1 (en) 2002-11-08
CA2364906C (en) 2006-01-10
DE60033280T2 (de) 2007-11-22
US20020137933A1 (en) 2002-09-26
CN1342158A (zh) 2002-03-27
TR200102562T2 (tr) 2002-02-21
KR20010102480A (ko) 2001-11-15
NO20014224L (no) 2001-08-31
AU756738B2 (en) 2003-01-23
WO2000052007A1 (en) 2000-09-08
AR044720A1 (es) 2005-10-05
RU2201928C1 (ru) 2003-04-10
US6417360B1 (en) 2002-07-09
ES2280198T3 (es) 2007-09-16
PL198815B1 (pl) 2008-07-31
NZ513671A (en) 2003-04-29
MA26776A1 (fr) 2004-12-20
EP1185525A1 (de) 2002-03-13
HRP20010630A2 (en) 2002-08-31
PT1185525E (pt) 2007-05-31
JP2002538156A (ja) 2002-11-12
KR100478798B1 (ko) 2005-03-24
DK1185525T3 (da) 2007-06-04
CN1342158B (zh) 2012-06-06
HUP0200080A2 (en) 2002-06-29
JP3488203B2 (ja) 2004-01-19
EP1185525B1 (de) 2007-02-07
CA2364906A1 (en) 2000-09-08
US6521631B2 (en) 2003-02-18

Similar Documents

Publication Publication Date Title
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID30401A (id) Turunan-turunan indol dan penggunaannya sebagai antagonis mcp-1
ID26420A (id) Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi
ID26099A (id) Turunan amida dan antagonis nosiseptin
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
CY2015041I2 (el) Παραγωγα 4- φαινυλπυριδινης και η χρηση αυτων ως ανταγωνιστες του υποδοχεα νκ-1
IS5581A (is) Ný efnasambönd og notkun þeirra sem jákvæðir beinar AMPA-viðtaka
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
ID19623A (id) Antagonis reseptor vitronektin
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
SI1170288T1 (en) Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists
ID19417A (id) TURUNAN-TURUNAN ASAM KARBOKSILAT BARU, PEMBUATAN DAN PEMAKAIANNYA SEBAGAI ANTAGONIS RESEPTOR ET a/ET b TERCAMPUR
ID16742A (id) Antagonis reseptor endotelin
HRP20000002B1 (en) Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
ID24714A (id) Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
PT1036072E (pt) Antagonistas de receptores de trombina
AU2002352476A8 (en) Urea derivatives and their use as vanilloid receptor antagonists
ID26223A (id) Antagonis reseptor vitronektin
ID30484A (id) Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID16274A (id) Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
ID26985A (id) Amina-amina polisiklik tiazolidin-2-ilidena, proses pembuatannya, dan penggunaannya a sebagai bahas farmasi